Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.09) per share. This is a 35.89 percent increase over losses of $(3.26) per share from the same period last year. The company reported $1.443 million in sales this quarter. This is a 0.82 percent decrease over sales of $1.455 million the same period last year.